Annual SG&A:
$41.05M+$14.91M(+57.03%)Summary
- As of today, JANX annual SG&A is $41.05 million, with the most recent change of +$14.91 million (+57.03%) on December 31, 2024.
- During the last 3 years, JANX annual SG&A has risen by +$30.72 million (+297.40%).
- JANX annual SG&A is now at all-time high.
Performance
JANX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$10.45M+$612.00K(+6.22%)Summary
- As of today, JANX quarterly SG&A is $10.45 million, with the most recent change of +$612.00 thousand (+6.22%) on June 30, 2025.
- Over the past year, JANX quarterly SG&A has increased by +$2.63 million (+33.67%).
- JANX quarterly SG&A is now -40.83% below its all-time high of $17.67 million, reached on September 30, 2024.
Performance
JANX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.01B-$105.64M(-11.66%)Summary
- As of today, JANX TTM SG&A is -$1.01 billion, with the most recent change of -$105.64 million (-11.66%) on June 30, 2025.
- Over the past year, JANX TTM SG&A has dropped by -$1.04 billion (-3718.46%).
- JANX TTM SG&A is now -6764.01% below its all-time high of -$14.74 million.
Performance
JANX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
JANX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +57.0% | +33.7% | -3718.5% |
| 3Y3 Years | +297.4% | +88.7% | -5695.6% |
| 5Y5 Years | +5217.0% | +2314.3% | -10000.0% |
JANX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +297.4% | -40.8% | +84.2% | -260.9% | at low |
| 5Y | 5-Year | at high | +5217.0% | -40.8% | +2377.3% | -6764.0% | at low |
| All-Time | All-Time | at high | +5217.0% | -40.8% | +3674.0% | -6764.0% | at low |
JANX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $10.45M(+6.2%) | $46.18M(+6.0%) |
| Mar 2025 | - | $9.84M(+19.8%) | $43.55M(+6.1%) |
| Dec 2024 | $41.05M(+57.0%) | $8.22M(-53.5%) | $41.05M(+4.7%) |
| Sep 2024 | - | $17.67M(+125.9%) | $39.19M(+40.2%) |
| Jun 2024 | - | $7.82M(+6.5%) | $27.96M(+3.5%) |
| Mar 2024 | - | $7.34M(+15.5%) | $27.02M(+3.4%) |
| Dec 2023 | $26.14M(+17.4%) | $6.36M(-1.3%) | $26.14M(+2.7%) |
| Sep 2023 | - | $6.44M(-6.4%) | $25.46M(+1.4%) |
| Jun 2023 | - | $6.88M(+6.5%) | $25.12M(+5.6%) |
| Mar 2023 | - | $6.46M(+13.9%) | $23.78M(+6.8%) |
| Dec 2022 | $22.26M | $5.68M(-6.9%) | $22.26M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $6.10M(+10.1%) | $20.52M(+13.5%) |
| Jun 2022 | - | $5.54M(+12.0%) | $18.08M(+24.4%) |
| Mar 2022 | - | $4.95M(+25.7%) | $14.54M(+40.7%) |
| Dec 2021 | $10.33M(+473.2%) | $3.94M(+7.7%) | $10.33M(+46.3%) |
| Sep 2021 | - | $3.66M(+83.1%) | $7.06M(+84.5%) |
| Jun 2021 | - | $2.00M(+170.2%) | $3.83M(+69.1%) |
| Mar 2021 | - | $739.00K(+10.3%) | $2.26M(+25.6%) |
| Dec 2020 | $1.80M(+133.4%) | $670.00K(+58.8%) | $1.80M(+59.2%) |
| Sep 2020 | - | $422.00K(-2.5%) | $1.13M(+59.4%) |
| Jun 2020 | - | $433.00K(+56.3%) | $710.00K(+156.3%) |
| Mar 2020 | - | $277.00K | $277.00K |
| Dec 2019 | $772.00K | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual SG&A year-on-year change?
- What is Janux Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Janux Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM SG&A year-on-year change?
What is Janux Therapeutics, Inc. annual SG&A?
The current annual SG&A of JANX is $41.05M
What is the all-time high annual SG&A for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual SG&A is $41.05M
What is Janux Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, JANX annual SG&A has changed by +$14.91M (+57.03%)
What is Janux Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of JANX is $10.45M
What is the all-time high quarterly SG&A for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly SG&A is $17.67M
What is Janux Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, JANX quarterly SG&A has changed by +$2.63M (+33.67%)
What is Janux Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of JANX is -$1.01B
What is the all-time high TTM SG&A for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM SG&A is -$14.74M
What is Janux Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, JANX TTM SG&A has changed by -$1.04B (-3718.46%)